To include your compound in the COVID-19 Resource Center, submit it here.

Luveris lutropin alpha regulatory update

FDA withdrew approval of an NDA for Merck’s infertility drug Luveris lutropin alpha.

Read the full 131 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE